Alvotech和梯瓦制药合作的重磅仿制药获批上市

智通财经02-26

美国食品和药物管理局(FDA)批准了Alvotech及其合作伙伴梯瓦制药的关节炎注射剂Simlandi (adalimumab-ryvk)的上市。Simlandi是美国艾伯维重磅关节炎治疗药物Humira的首个无柠檬酸盐、高浓度生物仿制药。适用于成人类风湿性关节炎、青少年特发性关节炎、成人银屑病关节炎、成人强直性脊柱炎、克罗恩病、成人溃疡性结肠炎、成人斑块性银屑病、成人化脓性汗腺炎、成人葡萄膜炎。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1199101132?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","is_english":false,"pubTime":"2024-02-26 20:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199101132","market":"us","top_or_hot":-1,"title":"Alvotech和梯瓦制药合作的重磅仿制药获批上市","media":"智通财经","content":"<div>\n<p>美国食品和药物管理局(FDA)批准了Alvotech及其合作伙伴梯瓦制药的关节炎注射剂Simlandi (adalimumab-ryvk)的上市。Simlandi是美国艾伯维重磅关节炎治疗药物Humira的首个无柠檬酸盐、高浓度生物仿制药。适用于成人类风湿性关节炎、青少年特发性关节炎、成人银屑病关节炎、成人强直性脊柱炎、克罗恩病、成人溃疡性结肠炎、成人斑块性银屑病、成人化脓性汗腺炎、成人葡萄膜炎。...</p>\n\n<a href=\"https://www.zhitongcaijing.com/content/detail/1076953.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alvotech和梯瓦制药合作的重磅仿制药获批上市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlvotech和梯瓦制药合作的重磅仿制药获批上市\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-26 20:08 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/content/detail/1076953.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国食品和药物管理局(FDA)批准了Alvotech及其合作伙伴梯瓦制药的关节炎注射剂Simlandi (adalimumab-ryvk)的上市。Simlandi是美国艾伯维重磅关节炎治疗药物Humira的首个无柠檬酸盐、高浓度生物仿制药。适用于成人类风湿性关节炎、青少年特发性关节炎、成人银屑病关节炎、成人强直性脊柱炎、克罗恩病、成人溃疡性结肠炎、成人斑块性银屑病、成人化脓性汗腺炎、成人葡萄膜炎。...</p>\n\n<a href=\"https://www.zhitongcaijing.com/content/detail/1076953.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEVA","symbol_name":"梯瓦制药","start_time":0,"source_url":"https://www.zhitongcaijing.com/content/detail/1076953.html","article_id":"1199101132","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199101132","pubTimestamp":1708949286,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"Simlandi是美国艾伯维重磅关节炎治疗药物Humira的首个无柠檬酸盐、高浓度生物仿制药。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"TEVA":"梯瓦制药","ALVO":"Alvotech"},"translate_title":"The heavy generic drugs cooperated by Alvotech and Tiva Pharmaceutical were approved for marketing","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/136227b70569b569b00d84af0c9e43c7","symbols_score_info":{"ALVO":1.1,"TEVA":1.1},"content_text":"美国食品和药物管理局(FDA)批准了Alvotech及其合作伙伴梯瓦制药的关节炎注射剂Simlandi (adalimumab-ryvk)的上市。Simlandi是美国艾伯维重磅关节炎治疗药物Humira的首个无柠檬酸盐、高浓度生物仿制药。适用于成人类风湿性关节炎、青少年特发性关节炎、成人银屑病关节炎、成人强直性脊柱炎、克罗恩病、成人溃疡性结肠炎、成人斑块性银屑病、成人化脓性汗腺炎、成人葡萄膜炎。它将获得40 mg/0.4ml注射剂的可互换专有权资格。作为2020年协议的一部分，梯瓦制药将成为Alvotech 在美国独家商业化Simlandi的战略合作伙伴。Simlandi是战略合作伙伴关系下首个获批的生物仿制药。这种注入预计将很快在美国推出，并具有可互换性。另外，Alvotech周一宣布，已接受投资者的要约，以约1.66亿美元的价格出售10,127,132股普通股。该生物技术公司将利用此次交易的净收益支持预期的生物仿制药发布，加强其生产能力，并用于一般公司用途和营运资金。这些股票预计将从Alvotech子公司Alvotech Manco ehf此前发行的库存股票中交付给投资者。该交易将在纳斯达克冰岛交易所进行。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199101132"}